ASSET PURCHASE AGREEMENTAsset Purchase Agreement • January 6th, 2022 • Cumberland Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledJanuary 6th, 2022 Company Industry JurisdictionThis ASSET PURCHASE AGREEMENT (this “Agreement”) is effective as of the 31st day of December 2021 (the “Effective Date”), by and among Kyowa Kirin, Inc., a corporation incorporated in the State of Delaware, having a principal place of business at 135 Route US-202, Suite 6, Bedminster, NJ 07921 (“KKUS”) and Cumberland Pharmaceuticals Inc., a corporation incorporated in the State of Tennessee, having a principal place of business at 2525 West End Avenue, Suite 950, Nashville, Tennessee (“Cumberland”). Cumberland and KKUS are referred to hereinafter individually as a “Party” and together as the “Parties.” Capitalized terms used herein shall be as defined in this Agreement.